Thus, monitoring the trend of the glucose level and dosing adjustments of sulfonylurea, glinide, and insulin to prevent hypoglycemia are particularly crucial and may decrease the mortality risks in advanced DKD patients transitioning to dialysis. Here, INS is linked to diabetic kidney disease.